
    
      A Double-Blind, Double-Dummy, Randomized, 4-Period, Crossover Study to Define the ECG Effects
      of SB204 Using a Clinical and a Supratherapeutic Dose Compared with Placebo and Moxifloxacin
      (a Positive Control) in Subjects with Acne Vulgaris: A Thorough ECG Study
    
  